Robert C. Doebele, M.D., Ph.D., University of Colorado Denver (IMAGE)

University of Colorado Anschutz Medical Campus

Robert C. Doebele, M.D., Ph.D., University of Colorado Denver

Caption

Doebele and colleagues report positive results in phase 1 trial of crizotinib against ROS1 lung cancer.

Credit

CU Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.